Related references
Note: Only part of the references are listed.Improving Influenza Vaccination Rates by Targeting Individuals not Seeking Early Seasonal Vaccination
Ayan Rage et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Universal vaccines: shifting to one for many or shooting too high too soon!
Mawieh Hamad
APMIS (2011)
Respiratory epithelial cells in innate immunity to influenza virus infection
Catherine J. Sanders et al.
CELL AND TISSUE RESEARCH (2011)
Optimizing immunization in pediatric special risk groups
Nigel W. Crawford et al.
EXPERT REVIEW OF VACCINES (2011)
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients
Bilal Mohty et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults
Christopher S. Ambrose et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2011)
The WHO Pandemic Influenza Preparedness Framework: A Milestone in Global Governance for Health
David P. Fidler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Synergistic Interactions of TLR2/6 and TLR9 Induce a High Level of Resistance to Lung Infection in Mice
Jeffrey M. Duggan et al.
JOURNAL OF IMMUNOLOGY (2011)
Generation and Characterization of Recombinant Pandemic Influenza A(H1N1) Viruses Resistant to Neuraminidase Inhibitors
Andres Pizzorno et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Influenza: Epidemiology, Clinical Features, Therapy, and Prevention
Nina M. Clark et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Influenza Drug Resistance
Andres Pizzorno et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: Supporting developing country production capacity through technology transfer
Martin Friede et al.
VACCINE (2011)
Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children
Sara Meier et al.
VACCINE (2011)
Stimulated Innate Resistance of Lung Epithelium Protects Mice Broadly against Bacteria and Fungi
Scott E. Evans et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Inducible Innate Resistance of Lung Epithelium to Infection
Scott E. Evans et al.
ANNUAL REVIEW OF PHYSIOLOGY (2010)
The need for quadrivalent vaccine against seasonal influenza
Robert B. Belshe
VACCINE (2010)
Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice
Yuk-Fai Lau et al.
VIROLOGY (2010)
Potentiation of Epithelial Innate Host Responses by Intercellular Communication
Tamas Dolowschiak et al.
PLOS PATHOGENS (2010)
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Joerg Vollmer et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Augmented Lung Inflammation Protects against Influenza A Pneumonia
Michael J. Tuvim et al.
PLOS ONE (2009)
A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic
Yuk-Fai Lau et al.
VACCINE (2009)
Activation of toll-like receptor signaling pathway for protection against influenza virus infection
J. P. Wong et al.
VACCINE (2009)
Allergic lung inflammation alters neither susceptibility to Streptococcus pneumoniae infection nor inducibility of innate resistance in mice
Cecilia G. Clement et al.
RESPIRATORY RESEARCH (2009)
Complications of viral influenza
Michael B. Rothberg et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice
Cecilia G. Clement et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Update on Avian Influenza A (H5N1) Virus Infection in Humans
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Mechanisms of disease: Acute lower respiratory tract infection
Joseph P. Mizgerd
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Environmental Factors Contributing to the Spread of H5N1 Avian Influenza in Mainland China
Li-Qun Fang et al.
PLOS ONE (2008)
Innate immunity to respiratory viruses
Jennifer P. Wang et al.
CELLULAR MICROBIOLOGY (2007)
Structure-activity relationship studies on the immune stimulatory effects of base-modified CpG Toll-like receptor 9 agonists
Marion Jurk et al.
CHEMMEDCHEM (2006)
Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant
Takeshi Ichinohe et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Mortality due to influenza in the United States - an annualized regression approach using multiple-cause mortality data
J Dushoff et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Antiviral response in pandemic influenza viruses
A Garcia-Sastre
EMERGING INFECTIOUS DISEASES (2006)
Therapeutic potential of Toll-like receptor 9 activation
Arthur M. Krieg
NATURE REVIEWS DRUG DISCOVERY (2006)
Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection
T Ichinohe et al.
JOURNAL OF VIROLOGY (2005)
Mucin is produced by Clara cells in the proximal airways of antigen-challenged mice
CM Evans et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2004)
Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities
J Vollmer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Overview: cause and prevention in biowarfare and bioterrorism
MR Hillman
VACCINE (2002)
Updating the accounts: global mortality of the 1918-1920 Spanish influenza pandemic
NPAS Johnson et al.
BULLETIN OF THE HISTORY OF MEDICINE (2002)
Share Paper
